My Account Log in

1 option

Oxidative stress and neuroprotection / H. Parvez, P. Riederer (eds.).

Holman Biotech Commons QP364.5 .J68 v.71 2006
Loading location information...

Available This item is available for access.

Log in to request item
Format:
Book
Contributor:
Parvez, H.
Riederer, P. (Peter)
Series:
Journal of neural transmission. Supplementum ; no. 71.
Journal of neural transmission. Supplement, 0303-6995 ; 71
Language:
English
Subjects (All):
Parkinson's disease.
Monoamine oxidase--Inhibitors.
Monoamine oxidase.
Nervous system--Degeneration--Molecular aspects.
Nervous system.
Oxidative stress.
Parkinson Disease--drug therapy.
Monoamine Oxidase Inhibitors--pharmacology.
Neuroprotective Agents--therapeutic use.
Oxidative Stress.
Parkinson Disease--physiopathology.
Nervous system--Degeneration.
Medical Subjects:
Parkinson Disease--drug therapy.
Monoamine Oxidase Inhibitors--pharmacology.
Neuroprotective Agents--therapeutic use.
Oxidative Stress.
Parkinson Disease--physiopathology.
Physical Description:
xiv, 264 pages : illustrations, portrait ; 29 cm.
Place of Publication:
Wien ; New York : Springer, [2006]
Summary:
This book deals with basic and clinical aspects of monoamine oxidase (MAO) subtypes A and B highlighting its importance in neurological and psychiatric diseases. Consequently the therapeutic actions of MAO-A and -B inhibitors in Parkinson 's disease (PK) and depression are the focus of several chapters. As MAO is the basis of the development of the "oxidative stress hypothesis" of PD, several chapters are devoted to iron and iron-induced oxidative stress in various experimental studies and clinical conditions. Based on these findings, new compounds have been developed which not only block MAO, but are in addition, either inhibitors of acetylcholine esterase or have iron chelating properties. The aspect of "preclinical" and "clinical" neuro protection as well as MAO neuroprotection are additional topics covered in this book. MAO, iron and neuroprotection are seen in the framework of general anti Parkinson 's therapy with chapters on levodopa, dopaminergic receptor agonists and clinical issues.
Notes:
Includes bibliographical references and index.
ISBN:
3211333274
9783211333273
OCLC:
84722336

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account